World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
51400
World Ranking
4520
National Ranking
2458

Overview

Victor L. Villemagne is affiliated with the University of Pittsburgh in the United States. Their research primarily focuses on Medicine, with significant contributions in subfields such as Psychiatry and Mental Health, Physiology, Radiology, Nuclear Medicine and Imaging, Neurology, and Cognitive Neuroscience.

The scientist's main areas of study encompass Dementia and Cognitive Impairment Research, Alzheimer's Disease Research and Treatments, Functional Brain Connectivity Studies, Advanced Neuroimaging Techniques and Applications, Medical Imaging Techniques and Applications, Neuroinflammation and Neurodegeneration Mechanisms, and Advanced MRI Techniques and Applications.

Recent publications by Victor L. Villemagne include:

  • "The Amyloid-β Pathway in Alzheimer's Disease" (2021, Molecular Psychiatry)
  • "Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias" (2020, The Lancet Neurology)
  • "Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease" (2021, Translational Psychiatry)
  • "Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture" (2020, Nature Communications)
  • "Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease" (2023, Nature Medicine)

The frequent co-authors collaborating with Victor L. Villemagne include:

  • Christopher C. Rowe
  • Vincent Doré
  • Colin L. Masters
  • Pierrick Bourgeat
  • Tharick A. Pascoal

Victor L. Villemagne has published extensively in several venues, among which the most prominent are:

  • Alzheimer's & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Alzheimer's Disease
  • Journal of Nuclear Medicine
  • Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring

Best Publications

  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

    Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease

    Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato

  • The Amyloid-β Pathway in Alzheimer's Disease.

    Harald Hampel;John Hardy;Kaj Blennow;Kaj Blennow;Christopher Chen

  • Imaging beta-amyloid burden in aging and dementia.

    Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong

  • The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

    Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio

  • Activation of memory circuits during cue-elicited cocaine craving

    Steven Grant;Edythe D. London;David B. Newlin;Victor L. Villemagne

  • Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

    Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat

  • Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

    Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis

  • Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

    Kerryn Elizabeth Pike;Gregory Raymond Savage;Victor L Villemagne;Steven Ng

  • Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

    Christopher C Rowe;Uwe Ackerman;William Browne;Rachel S Mulligan

  • Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

    Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

  • Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

    Una D. McCann;Dean F. Wong;Fuji Yokoi;Victor Villemagne

  • Tau imaging: early progress and future directions

    Victor L Villemagne;Michelle T Fodero-Tavoletti;Colin L Masters;Christopher C Rowe

  • Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.

    Gaël Chételat;Victor L. Villemagne;Pierrick Bourgeat;Kerryn E. Pike

  • Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

    P Edison;C C Rowe;J O Rinne;S Ng

  • Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

    Tammie L. S. Benzinger;Tyler Blazey;Clifford R. Jack;Robert A. Koeppe

  • 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease

    Michelle T Fodero-Tavoletti;Nobuyuki Okamura;Shozo Furumoto;Rachel S Mulligan

  • Amyloid Imaging with 18 F-Florbetaben in Alzheimer Disease and Other Dementias

    Victor L Villemagne;Kevin Ong;Rachel S Mulligan;Gerhard Holl

  • Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

    Victor L Villemagne;Victor L Villemagne;Vincent Doré;Samantha C Burnham;Colin L Masters

Frequent Co-Authors

Christopher C. Rowe
Christopher C. Rowe University of Melbourne
Ralph N. Martins
Ralph N. Martins Edith Cowan University
David Ames
David Ames University of Melbourne
Colin L. Masters
Colin L. Masters University of Melbourne
Olivier Salvado
Olivier Salvado Commonwealth Scientific and Industrial Research Organisation
Kathryn A. Ellis
Kathryn A. Ellis University of Melbourne
Paul Maruff
Paul Maruff University of Melbourne
Cassandra Szoeke
Cassandra Szoeke University of Melbourne
Yen Ying Lim
Yen Ying Lim Monash University
Ashley I. Bush
Ashley I. Bush Florey Institute of Neuroscience and Mental Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want to explore related fields or alternative routes, online degrees offer flexibility and diverse career options. For those passionate about wellness and dietetics, an online nutritionist degree can pave the way toward becoming a nutritionist or health coach, promoting healthy lifestyles in various settings.

Aspiring healthcare leaders may consider the best mha programs offered online. These programs provide essential management and leadership skills for advancing into hospital or clinic administration roles.

Registered nurses looking to further their careers can take advantage of the convenience offered by an online rn to bsn no clinicals program. This pathway allows RNs to earn a bachelor’s degree without additional clinical requirements, creating opportunities for career advancement.

For nurses seeking top credentials, the shortest dnp programs online can help you achieve a Doctor of Nursing Practice faster and more flexibly, positioning you for leadership or advanced practice roles in healthcare.

Best Scientists Citing Victor L. Villemagne

Trending Scientists

Recently Published Articles